Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-26

FDA Approved: LAMIVUDINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approves a supplemental abbreviated new drug application for Lamivudine from Apotex Corp., authorizing the continued manufacture and distribution of the gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

SUPPL AP for LAMIVUDINE (LAMIVUDINE)